Author

Allison L. Butler

Observed names: Allison L. Butler, Allison Butler, Butler, Allison

Institution: Rockefeller University

Observed institution: Rockefeller University

OpenAlex ID: A5035687358

Combination therapy with anti-HIV-1 antibodies maintains viral suppression

2018 · Pilar Mendoza, Henning Gruell, et al. · Nature · 564

Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals

2018 · Yotam Bar-On, Henning Gruell, et al. · Nature Medicine · 268

Prolonged viral suppression with anti-HIV-1 antibody therapy

2022 · Christian Gaebler, Lilian Nogueira, et al. · Nature · 214

Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity

2020 · Julia Niessl, Amy E. Baxter, et al. · Nature Medicine · 172

Relationship between latent and rebound viruses in a clinical trial of anti–HIV-1 antibody 3BNC117

2018 · Yehuda Z. Cohen, Julio C.C. Lorenzi, et al. · The Journal of Experimental Medicine · 138

Clonal CD4+ T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation

2018 · Lillian B. Cohn, Israel T. da Silva, et al. · Nature Medicine · 137

Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study

2019 · Yehuda Z. Cohen, Allison L. Butler, et al. · PLoS ONE · 90

Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells

2017 · Yehuda Z. Cohen, Julio C. C. Lorenzi, et al. · Journal of Virology · 51

Safety, Pharmacokinetics, and Immunogenicity of Combination Long-Acting Broadly Neutralizing Anti-HIV-1 Antibodies 3BNC117-LS and 10-1074-LS in People with and without HIV

2025 · Kelly E. Seaton, Yehuda Z. Cohen, et al. · SSRN Electronic Journal

Works count: 10

Citation count: 1,634

H-index: 8

I10-index: 8